aponvie
(APREPITANT)Heron Therapeutics, Inc.
Usage: APONVIE is indicated for the prevention of postoperative nausea and vomiting (PONV) in adults. It is not studied for treating already established nausea and vomiting.
4 results
cinvanti
(aprepitant)Heron Therapeutics, Inc.Usage: CINVANTI is indicated for the prevention of acute and delayed nausea and vomiting in adults undergoing highly and moderately emetogenic cancer chemotherapy, used in combination with other antiemetics and in specific dosing regimens. It is not studied for treating established nausea and vomiting.sustol
(granisetron)Heron Therapeutics, Inc.Usage: SUSTOL is indicated for the prevention of acute and delayed nausea and vomiting in adults undergoing moderately emetogenic chemotherapy (MEC) or anthracycline and cyclophosphamide (AC) regimens, in combination with other antiemetics.zynrelef
(BUPIVACAINE and MELOXICAM)Heron Therapeutics, Inc.Usage: ZYNRELEF is indicated for postsurgical analgesia in adults for up to 72 hours following soft tissue and orthopedic surgical procedures, including foot and ankle surgeries. Its safety and efficacy have not been established in highly vascular surgeries like intrathoracic, extensive spinal, and head and neck procedures.